RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS
6. NVDA
7. AWK
8. DRI
9. ULS
10. CRL

Go back to RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication

Truist Securities Downgrades Gilead Sciences (GILD) to Hold

February 22, 2024 6:04 AM EST

Truist Securities analyst Robyn Karnauskas downgraded Gilead Sciences (NASDAQ: GILD) from Buy to Hold with a price target of $82.00 (from $91.00).

The analyst comments "We view GILD/RCUS (RCUS, Buy) re-strategizing to focus on chemo combos in lung and other lrg markets as smart,... More